BYSI
BYSI
NASDAQ · Biotechnology

Beyondspring Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.85
-0.15 (-14.58%)
As of Aug 15, 2:22 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +5,070.4% upside
Low Target $29.80
Average Target $44.00
High Target $55.04
Current Price $0.85
Current
$0.85
Target
$44.00
$29.80 $44.00 avg $55.04
Scenario Analysis
Bear Case
$29.80
3,401.8%
Low target
Base Case
$44.00
+5,070.4%
Avg target
Bull Case
$55.04
+6,367.7%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$2.44
-65.1% from high
52-Week Low
$0.73
+16.6% from low
Target vs 52W High
$44.00
+1,703.3% vs high
Next Earnings Report
Sep 4, 2026
19d
until earnings
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.4%